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Abstract
Osteoarthritis (OA) can be defined as degenerative joint disease that is caused by the breakdown
of joint cartilage and the underlying bones due to friction as a result of aging and repeated back
and forth motion of the joint. This can occur in any of the joints but those most commonly
affected are the hands, knees, hips, and spine. The most common symptoms associated with OA
are pain and stiffness which can ultimately limit or reduce mobility and quality of life. It is
primarily a disease of aging and occurs most often in older adults. An effective surgical
intervention for treating symptomatic, end-stage knee osteoarthritis is known as Total Knee
Arthroplasty (TKA), which is commonly used to improve mobility and relieve pain and remains
the gold standard (Duchman, Gao, Pugely, Martin, & Callaghan, 2014). This paper is going to
examine a case report highlighting a controversy in treatment strategy regarding the optimal
timing of surgery on the contralateral knee after the first TKA for patients with symptomatic
bilateral OA undergoing staged TKAs. A literature review looking at the two different methods
of Staged-Bilateral TKAs (BTKA), same hospitalization but days apart vs. separate
hospitalization, factors influencing medical decision making including risk factors for patient
selection, perioperative complications, and functional outcomes. Understanding the factors that
influence the medical decision making and the rationale for the different treatment strategies will
help primary care providers to better educate, answer questions, and provide better overall care
for their patients undergoing TKA or BTKA.
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Case Report: Optimal Time between Procedures for Contralateral Total Knee Arthroplasty
Background
The case study in this report involves a 67-year-old male that presents in clinic for a preoperative physical and clearance for a scheduled right total knee arthroplasty (TKA). He has
symptomatic end-stage knee osteoarthritis and is still recovering from a left TKA approximately
eight weeks prior to this visit. In obtaining a health history, he did complain of right knee
osteoarthritis symptoms of pain with increased ambulation, stiffness at rest and in the morning
upon waking, and occasional swelling of the knee joint. These symptoms have become resistant
to nonsurgical treatments, including ibuprofen/NSAIDS, ice pack therapy, and elevation of the
extremity. He is not yet fully recovered from his recent LTKA, but has completed his
rehabilitation, feels much better, and only uses a cane for walking assistance at times due to the
degenerative disease that remains in his right knee. His physical examination was mostly
unremarkable except for mild BP elevation and mild inflammation of left knee post-replacement.
Since this patient had a staged bilateral TKA approximately eight weeks ago and now presents
for pre-op clearance for a second primary knee joint replacement surgery on the contralateral
side, the question regarding the optimal timing interval for patients between surgical procedures
would seem prudent in caring for this and other patients in the future.
This report will further examine the controversy in treatment strategy regarding the
optimal timing of surgery on the contralateral knee after the first TKA for patients with
symptomatic bilateral osteoarthritis (OA) undergoing staged bilateral TKA (BTKA) by
discussing the two types of BTKA (simultaneous and staged), the factors involved in medical
decision making such as patient selection criteria for BTKA, risk factors, complications, and

OPTIMAL TIME BETWEEN PROCEDURES

5

outcomes associated with the type of bilateral total knee arthroplasty the patient is eligible to
undergo.
Pre-Operative History and Physical Examination
PATIENT NAME: J. D.

AGE: 67

SEX: Male

DOB: xx/xx/1949

CHIEF COMPLAINT: Pre-Operative evaluation for Right Total Knee Arthroplasty (TKA)
HISTORY OF PRESENT ILLNESS: This is a 67-year-old Caucasian male that is here for a
pre-op physical and clearance for a RTKA which is scheduled with Dr. G. at Altru Hospital on
2/28/2016. He states he “feels good” but has had several months of right knee joint pain that is
deep, achy, and exacerbated with longer walks or climbing stairs. He will get occasional mild
swelling in the right knee from increased activity. He also notices stiffness during rest as well as
upon waking in the morning, but this usually lasts a short time. Treatments he has tried include
ice packs, elevation of the extremity, and ibuprofen. He states that all of these “help”, but do not
alleviate the pain completely (9-10/10 to 4/10). Mr. J. D. is s/p Left TKA (12/21/15) and states
that he had nausea as a post-op complication, otherwise it went well. He has completed the
rehabilitation program for his s/p LTKA and had complaints of mild numbness and swelling in
his left knee, however this has improved with ibuprofen prn.
PAST MEDICAL HISTORY:
Medical:
 Diabetes Mellitus, Type 1 – diagnosed at age 25, insulin pump x 3yrs
 Hypertension
 Hyperlipidemia
 Polyosteoarthritis
Surgical:
 s/p Appendectomy
 s/p Inguinal Herniorrhaphy B/L
 s/p Right Meniscectomy
 s/p Left TKA – (Dr. G., Altru Hospital - 12/21/15)
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s/p Insulin Pump - 2013

Medications:





Losartan 10mg PO once daily in the morning
ASA 81mg PO once daily in the morning
Simvastatin 80mg PO once daily at bedtime
Novolog Insulin via pump

Allergies: NKDA
FAMILY HISTORY: Noncontributory. Daughter is healthy.
PSYCHOSOCIAL HISTORY: Mr. J.D. is married and lives with his wife in Grand Forks. He
has a daughter who is married and also lives in Grand Forks. His wife is a retired Registered
Nurse. He is a retired accountant, but does do some work occasionally with his son-in-law who
has a new construction business. He has a 20-pk year history of smoking cigarettes and
consumes one alcoholic drink per day. He stays active with walking, but this has decreased due
to the increased symptoms he’s experiencing in his right knee. He tries to maintain a low sodium,
diabetic diet, but is not always consistent.
REVIEW OF SYSTEMS:
Constitutional: “I feel good.” Denies headache, fever, chills, night sweats, sore throat,
cough, dyspnea, chest pain, or abdominal pain. No insomnia or sleep disturbances. Good
appetite.
Eyes: Denies visual changes, blurred vision, or eye drainage. Wears prescription
eyeglasses.
E/N/T: Denies ear pain, hearing loss or changes. Denies nasal/sinus congestion or
drainage, sore throat, swelling, or voice hoarseness. Denies any current dental problems.
Cardiovascular: Denies chest pain, pressure, palpitations, or history of arrhythmia.
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Respiratory: Denies cough, dyspnea, wheeze, or hemoptysis. Denies obstructive sleep
apnea.
Gastrointestinal: Denies abdominal pain, nausea, vomiting, GERD, constipation or
diarrhea.
Genitourinary: Denies dysuria or hematuria.
Musculoskeletal: Positive for Left knee numbness, swelling, and pain with ambulation.
Positive history of severe osteoarthritis. He is s/p LTKA on 12/21/15. Uses cane with
ambulation at times.
Integumentary: Denies rashes or changes in moles. No skin lesions or concerns at this
time.
Neurological: Denies headaches, dizziness, or tremors. Positive for numbness in Left
knee.
Hematologic/Lymphatic: Denies easy bruising on ASA. Denies coagulopathy/blood
disorders or lymphadenopathy.
Endocrine: Denies thyroid problems, temperature intolerances. Positive for T1DM,
insulin pump.
Allergic/Immunologic: Denies seasonal allergies or asthma. Denies frequent/recurrent
infection.
Psychiatric: Denies anxiety, depression, mental illness, illicit drug, or alcohol abuse.
PHYSICAL EXAMINATION:
General: Mr. J. D. is a pleasant, well-groomed, Caucasian, 67-year-old male, who
appears his stated age. He is alert, oriented, cooperative, and sitting in chair in the exam
room in no acute distress. He is a good historian and answers all questions appropriately.
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Vital Signs: BP 158/94; P 76 and regular; R 20 and regular; T 98.8°F.
Skin: Warm, dry, and intact. No lesions or rashes noted. No cyanosis, pallor, or jaundice.
Brittle yellowish toenails bilaterally.
HEENT: Head: Normocephalic, atraumatic. Eyes: Symmetric, PERRL, sclera white,
conjunctiva pink; wearing eyeglasses. Ears: Symmetric, nontender, hearing is appropriate
to conversation. No erythema or fluid noted, canals patent, TMs intact bilaterally. Nose:
No drainage, mucosa pink and moist, and septum midline, nares patent bilaterally.
Frontal/Maxillary sinuses non-tender to palpation. Mouth/Throat: Buccal mucosa and
gingiva pink, moist without any lesions. Pharynx clear without erythema. Tongue and
uvula are midline, pink, and moist. Swallow reflex appropriate.
Neck: Supple. Trachea midline, thyroid nonpalpable, smooth, nontender to palpation, no
goiter. LNs not enlarged and nontender to palpation.
Respiratory: Normal chest wall appearance and symmetric expansion. Lung fields CTA
bilaterally. Regular, easy respirations.
Cardiovascular: Normal S1, S2, RRR, no murmur, rub, or gallop. Radial and DP pulses
2+, equal and symmetric. Trace edema noted Left knee.
Abdomen: Flat, soft, nontender, nondistended, bowel sounds positive in all four
quadrants. No guarding or rebound. Insulin pump port in place noted at right lateral
abdomen and RLQ blood sugar sensor also in place and intact.
Genitalia: Deferred; not examined.
Rectal: Deferred; not examined.
Musculoskeletal: Moves all extremities. Left knee with trace edema/swelling, slightly
warm to palpation, no erythema, well-healed surgical scar anterior knee s/p LTKA. Right
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lower extremity is within normal limits. Able to step up and step down from exam table
unassisted without difficulty.
Neurological: Alert and oriented x 3; normal speech pattern; mood and affect appropriate
to situation. No tremors. CN II-XII grossly intact. Motor: 5/5 UE’s and 4/5 LE’s. Sensory
intact to sharp and light touch stimulation. DTRs 2+ B/L and symmetrical.
Laboratory Data:


CBC: WBC 8500; RBC 3.0; Hct 34.5; Hgb 12.0; Plt 400, otherwise WNL.



CMP: Na 140, K 3.9, Cl 105, CO₂ 28, Cr 0.8, BUN 9, Gluc 96



ECG: normal sinus rhythm, no ectopic beats, no ischemia.

ASSESSMENT/PLAN:
1. Osteoarthritis of knee, unspecified, ICD-10:M17.9 – s/p LTKA 12/21/15, finished
rehab, some c/o numbness/swelling, mild pain with ambulation, otherwise appears to be
healing well. His Right knee has increased symptoms of pain with ambulation not well
relieved with rest, ibuprofen, ice pack, or elevation. Has RTKA scheduled with Dr. G. on
2/28/16 (approximately 8 weeks post LTKA). Based on this patient’s history and physical
exam, ECG, lab data, and his overall health I feel he is an appropriate candidate for his
scheduled RTKA. Discussed with patient and he is in agreement with this plan.
2. Essential (Primary) Hypertension, ICD-10: I10 – BP is elevated (150s/90s) in the
office today, he reports home BPs have been in the normal range. Continue home BP
checks, amlodipine and low-dose ASA for cardiovascular protection.
3. Type 1 Diabetes Mellitus without complications, ICD-10:E10.9 – good overall control,
on Novolog insulin via insulin pump. Good B/L foot exam, reviewed DM complications.
Continue current plan of care.
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4. Hyperlipidemia, unspecified, ICD-10:E78.5 – continue exercise regimen, Therapeutic
Lifestyle Changes (TLC), and statin therapy.
5. Patient is to RTC as needed or in 6 months for routine follow-up and associated lab work.

Literature Review
One of the most common causes of disability among older adults is osteoarthritis of the
knee (OA). The prevalence of OA will continue to rise as the aging of the “baby boomer”
generation and the obese population increase (Maradit Kremers et al., 2015; Van Manen, Nace,
& Mont, 2012). Roughly 27 million U.S. adults are affected by osteoarthritis currently and it is
predicted that the number of U.S. adults with OA will reach 67 million by the year 2030 (Van
Manen et al., 2012). While it is important to note that in 2008, the American Academy of
Orthopaedic Surgeons (AAOS) issued clinical practice guidelines for non-operative treatment
options for patients with OA of the knee, this paper will focus on the most effective operative
treatment for end-stage degenerative osteoarthritis, the total knee arthroplasty (TKA) (S.
Memtsoudis et al., 2009; Van Manen et al., 2012). The TKA was first performed in the 1970’s
and now the operation is commonly performed with more than 620,000 procedures performed in
the U.S. in 2009 (Weinstein et al., 2013). TKA is “beneficial to a majority of recipients and is
cost effective for quality of life assessments” (Van Manen et al., 2012, p. 713). The goals of
TKA are to reduce pain, return to the activities of daily living, restore mechanical alignment in
the joint, preserve the joint line, balance the ligaments, and restore a normal Q angle (Van Manen
et al., 2012). For primary care providers the decision when to move forward with TKA is “a
complex process” for the provider and the patient in which factors are taken into account like
“severity of symptoms, age, comorbidities, and socioeconomic variances” (Van Manen et al.,
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2012, p. 714). As with the patient in this case, the medical decision making regarding this patient
who had a staged bilateral TKA approximately eight weeks ago and now presents for pre-op
clearance for second primary knee joint replacement surgery on the contralateral side. This
situation represents a complex process as to what the optimal timing interval would be for
patients between surgical procedures.
A literature review was conducted to determine the optimal timing of surgery on the
contralateral knee after a patient has undergone their first TKA in a staged BTKA and the
rationale for this medical treatment strategy. A search was conducted utilizing the University of
North Dakota Harley E. French Library of the Health Sciences website. A systematic search of
the literature was performed using the online database CINAHL employing Boolean/Phrase
search mode and terms of knee AND arthroplasty AND bilateral with limitations of Peer
Reviewed, English language, as well as publication date to within the last seven years, a total of
114 articles were generated. After adding the term AND staged to the previous terms, the
number of articles was reduced to fifteen. After reviewing the list of generated articles, three
articles were selected and considered relevant to the purpose of this case report. From the three
selected articles, eight additional relevant articles were found in a review of the articles reference
sections. The grading system this author chose to use in regard to gaining a better understanding
of the quality and validity of the research evidence within the literature articles was the American
Academy of Orthopaedic Surgeons (AAOS) Evidence Rating System which utilizes an “ABCI”
rating system, where “consistent Level I studies” are considered “Good evidence” and given the
highest evidence rating and recommendation of “A - Recommends” (Total Knee Replacement |
Performance Measurement Set | PCPI Approved January 2013, 2012). The rating and
recommendation of “B - Suggested” is given for “consistent Level II and III studies” and
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considered “Fair evidence” (Total Knee Replacement | Performance Measurement Set | PCPI
Approved January 2013, 2012). The rating and recommendation of “C – Option” is given for
“Level IV or V studies” and considered “Poor quality evidence” (Total Knee Replacement |
Performance Measurement Set | PCPI Approved January 2013, 2012). The lowest rating and
recommendation of “I – Neither not recommended nor recommended” is given to studies “when
there is insufficient or conflicting evidence” (Total Knee Replacement | Performance
Measurement Set | PCPI Approved January 2013, 2012). The AAOS Evidence Rating System is
used in conjunction with the Level of Evidence chart, which is an adaptation of “The Oxford
2011 Levels of Evidence” from the Oxford Centre for Evidence-Based Medicine (OCEBM)
("Level of Evidence | The Journal of Bone & Joint Surgery," 2016). This chart assists in grading
the level of evidence on a scale of “Level I-V”, in which “Level I” is the highest level of
evidence given to studies such as randomized controlled trials (RCTs) ("Level of Evidence | The
Journal of Bone & Joint Surgery," 2016). A grade of “Level II” is given to studies such as
prospective cohort studies, control arm of randomized trial, or observational studies with
dramatic effect ("Level of Evidence | The Journal of Bone & Joint Surgery," 2016). A grade of
“Level III” is given to studies such as retrospective cohort studies, or case-control studies
("Level of Evidence | The Journal of Bone & Joint Surgery," 2016). A grade of “Level IV” is
given to studies such as a case series or historically controlled studies ("Level of Evidence | The
Journal of Bone & Joint Surgery," 2016). A grade of “Level V” is the lowest level of evidence
and is given to mechanism-based reasoning studies ("Level of Evidence | The Journal of Bone &
Joint Surgery," 2016). This Level of Evidence chart also takes into account and consideration of
the type of study (Diagnostic, Prognostic, Therapeutic, and Economic) as well as the primary
research question ("Level of Evidence | The Journal of Bone & Joint Surgery," 2016) when
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grading the quality, strength, and validity of research articles for an appropriate level of
evidence. This can be very important when there is limited research in higher level studies.
Differences in Staged BTKA
There are two versions of staged bilateral TKA and the primary difference between the
two involves the timing in which the second surgery is performed on the contralateral knee after
a patient has undergone their first TKA. In a same-admission staged BTKA, the patient has a
TKA on the primary knee and then will stage the second TKA for the contralateral knee
generally within an interval of two to seven days apart (S. Memtsoudis et al., 2009). In a staged
BTKA, the patient will undergo a TKA during one hospital admission, recover from the surgery
and complete rehabilitation before undergoing a second surgery on the contralateral knee. This
is where the treatment strategy regarding the optimal timing of surgery on the contralateral knee
is largely controversial.
Risk Factors | Complications
In a retrospective cohort study (Level III) performed by Poultsides, Memtsoudis, Do,
Sculco, and Figgie (2015), they compared 30-day mortality, in-hospital complication rates, and
blood transfusion rates between patients undergoing same-admission staged BTKA and patients
undergoing BTKA staged within 1 year. They examined institutional data for patients undergoing
same-admission staged (n=149) and those undergoing staged BTKA (n=1557) from 1998-2011.
While the age of the groups were similar, the same-admission staged group were more likely to
be males and had more medical comorbidities such as CAD with inducible ischemia, CHF,
COPD, uncontrolled DM, renal failure, morbid obesity, history of VTE, or older than 75 years.
Regression models looked at the association between surgery type and occurrence of
complications. The results showed no difference in 30-day mortality between the groups (0% vs.
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0.06%; p=0.754) and no difference in local complication rates (0.7% vs. 0.8%; p=1.000).
However, the same-admission staged group was shown to be three times more likely to develop a
minor complication and two times more likely to develop a major complication. More acute
post-op anemia and blood transfusion occurred in this group as well. The authors concluded that
patients with higher comorbidity burden may benefit by undergoing staged BTKA within 1 year
rather than same-admission staged BTKA due to the increased perioperative morbidity
association.
S. Memtsoudis et al. (2009), performed a retrospective cohort study (Level III) that
looked at a nationwide sample of inpatient data from 1998-2006 and identified patients that
underwent unilateral (UTKA) and BTKA procedures performed on the same day (simultaneous)
and separate days (staged) during the same hospitalization. In-hospital mortality and
complications that were procedure-related were calculated and compared between the groups.
Independent risk factors for morbidity and mortality were also identified. The results of the study
revealed an increased incidence of both perioperative complications and in-hospital mortality
among those hospital patients undergoing BTKA compared to those hospital patients undergoing
UTKA procedures. Their results also showed that staged procedures performed during the same
hospitalization were associated with a higher incidence of “most studied in-hospital
complications when compared with simultaneous surgeries, and offered no mortality benefit
(0.29% for simultaneous and 0.26% for staged BTKA; P=0.2875)” (S. Memtsoudis et al., 2009,
p. 1213). These findings are consistent with a number of studies in the literature reviewed that
undergoing BTKA, simultaneous or staged same-admission procedures, “carried an increased
adjusted risk of in-hospital mortality and greater incidence of in-hospital complications when
compared to unilateral TKA procedures” (S. Memtsoudis et al., 2009, p. 1215). However, the
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caveat to a study by Poultsides et al. (2015) was that for BTKA (same-day or simultaneous) in
one hospitalization to be “performed safely without increased perioperative morbidity and
mortality compared with staged BTKA is if a selective preoperative screening process for a
potential candidate is used” (Poultsides et al., 2015, p. 191). S. Memtsoudis et al. (2009), notes
that one reason why a selective preoperative screening process is done is to further minimize
potential unfavorable outcomes related to this elective surgical procedure. They also concluded
that more studies are needed to determine if conditions for BTKA (staged or simultaneous)
during one hospitalization can be performed devoid of increased risk and until then, they cannot
recommend them based upon their findings. Also, in a consensus statement by S. G. Memtsoudis
et al. (2013), there was a general agreement that the greater the comorbidity burden, the higher
the risk for adverse outcomes and emphasized the importance of patient selection for when
considering candidates for BTKAs.
In a retrospective cohort study (Level III), Barrett et al. (2006) examined when BTKA is
indicated, if it is preferable to perform BTKA (simultaneous) during the same hospitalization or
to stage the procedure in two separate hospitalizations. They also analyze what is known
regarding reports of higher risk of pulmonary embolism (PE) after simultaneous BTKA. They
looked at 122,385 U.S Medicare enrollees with the ICD-9-CM procedure code “81.54”
indicating (total knee replacement) and tied it to their surgeon’s CPT code “27447” indicating
the TKA for the years 1999, 2000, and 2001. They compared two groups, patients that had
simultaneous BTKA (n=8324) and patients that had staged BTKA (n=17,996), with “regard to
their demographic attributes, comorbidities, geographic distribution, hospital and surgeon
volume, and probability of PE in the first three months preoperatively” (Barrett et al., 2006, p.
2147). The results of their study showed that high-volume hospitals and surgeons were more
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likely to perform simultaneous BTKA than there low-volume counterparts (Barrett et al., 2006).
In terms of geographical patterns, hospitals in the northeastern states were most likely to perform
simultaneous BTKA. Gender also played a role as the number of simultaneous BTKAs were
performed on men than on women. Lastly, the probability of having a symptomatic PE in the
first three months after a TKA was 1.44% for those patients who underwent a simultaneous
BTKA, 0.87% for patients who underwent unilateral TKA, and 0.54% for patients who
underwent the first of two staged TKAs (Barrett et al., 2006). Of importance is that “the
difference among the three groups was highly significant (log-rank p < 0.0001)” (Barrett et al.,
2006, p. 2149). They found that the group that underwent the staged procedures “there was no
clinically meaningful differences in the rate of PE after the procedure according to how far apart
the procedures had been staged” (Barrett et al., 2006, p. 2149). In terms of probability of PE in
patients that underwent unilateral or staged procedure “in the first three months after the first (or
only) procedure was 0.81%” (Barrett et al., 2006, p. 2149). Barrett et al. (2006), postulate that
“the increased operative time involved in a simultaneous bilateral procedure, the surgical
intervention in both lower extremities (where emboli typically originate) and perhaps a more
prolonged period of relative immobility constitute possible explanations” for the higher
probability of PE after simultaneous BTKA in comparison with the probability after a unilateral
TKA (Barrett et al., 2006, p. 2150). The implications of these data are significant in the medical
decision making when providing treatment to patients with symptomatic degenerative bilateral
knee osteoarthritis, especially when considering discussing surgical treatment options such as
TKA with your patient.
Functional Outcome
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Maxwell et al. (2013), performed a prospective cohort study (Level II) that looked at the
“relationship between the pre-operative pain status of the contralateral knee and the risk of poor
post-operative functional outcome in patients who underwent knee arthroplasty” (Maxwell et al.,
2013, p. 989). They analyzed 271 subjects out of 3026 enrolled in the Multicenter Osteoarthritis
Study (MOST) aged 50-79 years and “who either already had, or were at risk for, knee
osteoarthritis” (Maxwell et al., 2013, p. 990). These subjects had a previous knee arthroplasty
since they enrolled. In terms of demographics, 86% of the patients were white, 72% were female,
and the mean age was 67 years. Pain severity of the contralateral knee was measured prior to the
TKA utilizing the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
pain scale, their scores were grouped into four categories (0, 1-4, 5-9, and 10-20).The Patient
Acceptable Symptom State (PASS) outcome tool and a clinical performance of walking speed
was used to determine poor post-arthroplasty function six months or more after TKA. The
relationship between the severity of contralateral knee pain and the functional outcomes were
evaluated using Poisson regression. Their findings revealed that 72 out of 264 (27%) patients
showed poor post-arthroplasty function as they were unable to attain the threshold PASS score,
and 76 out of 250 (30%) patients demonstrated a slow walking speed (Maxwell et al., 2013). A
relationship emerged demonstrating that as the “pain in the contralateral knee increased, there
was a steady increase in the proportion with poor post-arthroplasty function (p < 0.0001 for
PASS and p = 0.04 for slow walking speed) among those with unilateral knee arthroplasty”
(Maxwell et al., 2013, p. 991). In comparison with patients without pre-arthroplasty pain in the
contralateral knee, “those in the highest category of contralateral pain severity had 4.1 times the
risk (95% CI, 1.5 to 11.5) of having poor self-reported post-arthroplasty function (Maxwell et al.,
2013, p. 989). Patients who have had a TKA bilaterally at the time of outcome collection were
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less likely to report poor function than those who have had one knee replaced (Maxwell et al.,
2013). These authors concluded that “pre-operative pain in the contralateral knee is strongly
associated with self-reported post-arthroplasty functional outcome and may therefore be a useful
indicator of prognosis or a potential target of perioperative intervention”(Maxwell et al., 2013, p.
989).
Optimal Timing
Ishii, Noguchi, Takeda, Sato, and Toyabe (2014), performed a prospective cohort study
(Level II) that evaluated the time between the first and second surgeries for staged BTKAs when
the timing interval is determined by the patient for the second surgery. In addition, correlations
between the timing of the second surgery and the characteristics of the patient were analyzed.
The sample consisted of patients (n=86; 10 males/76 females) with bilateral knee osteoarthritis
and no significant differences between right or left knees before the patients underwent the first
TKA. The follow-up interval after the first TKA had a mean of 96 months. In this study, the first
TKA and the timing of the second (contralateral) TKA were determined solely by the patient,
which was dependent upon the patient’s perception of their ability to tolerate the post-operative
effects of knee surgery, primarily the symptoms of pain and limitations to activities of daily
living (Ishii et al., 2014). Their results showed that the median time between the first TKA and
second contralateral TKA procedure for staged BTKA was approximately 1 year (12.5 months),
with 50% of the patients the second TKA within 12 months. There were no significant
correlations between timing of the second procedure and patient characteristics such as BMI,
age, or gender. A few limitations that may affect this study include a small sample size (n=86),
sociocultural differences and economic factors more specific to Japan may have influenced the
patient’s timing interval for surgery and thus may not be as generalizable to patients living
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outside of Japan, in the U.S. such economic factors like work leave policies and high deductible
insurance costs, as well as the ability for the patient to determine the timing of their second TKA
were perhaps biased by the patient characteristics (Ishii et al., 2014).
S. G. Memtsoudis et al. (2013) developed a consensus statement from the consensus
conference on various topics surrounding BTKA and the controversy that surrounds aspects of
medical decision making. Forty experts were asked to summarize the current body of literature
on each of the selected topics in the form of a white paper. A thorough literature review was
conducted and white papers were peer reviewed. One of the aspects involves same-day BTKAs
in which the experts concluded that if a patient is not deemed a suitable candidate for same-day
BTKA, a second TKA should be scheduled no sooner than three months after the first (S. G.
Memtsoudis et al., 2013). They also agree that same-day BTKAs increase medical risk, and thus
a systematic approach to the management of patients should be taken to minimize complications
(S. G. Memtsoudis et al., 2013). Another topic relevant to this patient case involves the optimal
time interval between procedures if simultaneous BTKAs are not deemed appropriate (S. G.
Memtsoudis et al., 2013). The authors provide recommendations on a theoretical basis as there
is a lack of specific evidence on this. However, 81% of expert participants on the panel agreed
that patients not deemed a candidate for same-day BTKA, a second TKA should be scheduled for
3 months or later (S. G. Memtsoudis et al., 2013). In addition, staging within one hospitalization
should not be routinely performed and used only in rare circumstances. The authors further note
that there is a lack of data on the subject of “appropriate timing between stages for staged
BTKAs, and no definitive conclusions can be drawn” (S. G. Memtsoudis et al., 2013, p. 2654).
In spite of inconclusive data, there is some evidence to suggest that “staging BTKAs during the
same hospitalization or within 3 months of the first surgery may be associated with a greater risk
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of mortality and complications” (S. G. Memtsoudis et al., 2013, p. 2654). Also, it is debatable
whether a rapid staged surgical strategy (within the same hospitalization but days apart) should
be used in patients not adequately deemed as candidates for same-day surgery (S. G. Memtsoudis
et al., 2013).
Summary
While the treatment strategy regarding the optimal timing of surgery on the contralateral
knee after the first TKA for patients with symptomatic bilateral OA undergoing staged BTKAs is
still largely controversial, primarily due to a lack of specific evidence on this issue, much of the
literature suggests that the second TKA should be scheduled 3 months or later after the primary
TKA procedure. The research indicates that there is a higher likelihood of better functional
outcomes after the first surgical knee has healed and regained its function. Primary care
providers will be better able to educate, answer pertinent questions, and provide better overall
care for their patients planning to undergo TKA or BTKA by understanding the various factors
that influence medical decision making and the rationale for the different treatment strategies.
Learning Points


Patients not deemed a candidate for same-day BTKAs, should be scheduled for second
TKA no sooner than 3 months after the first.



There is no consensus to assist providers and their patients in their medical decisionmaking process concerning whether to proceed with same-day BTKAs or staged BTKAs



Literature is lacking on the management of patients undergoing BTKAs.



Pre-arthroplasty function is a strong predictor of post-arthroplasty function.



Pre-operative pain in the contralateral knee is strongly associated with self-reported postarthroplasty functional outcome.
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